Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

Clinical trial NCT01762046 · COMPLETED

Trial details

NCT number: NCT01762046
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-01-01
Primary completion: 2015-12-01
Enrollment: 1033

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.